Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ifosfamide encephalopathy: a reappraisal.

S W Watkin1, D J Husband, J A Green

  • 1University of Liverpool, Department of Radiation Oncology, U.K.

European Journal of Cancer & Clinical Oncology
|September 1, 1989
PubMed
Summary

Ifosfamide/mesna chemotherapy can cause serious encephalopathy, characterized by confusion and agitation, often linked to low potassium levels. This severe complication is difficult to predict and may lead to irreversible neurological damage.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relative sensitivity of plastic scintillator: A comparative analysis with 60Co gamma rays, deuterium-deuterium, and deuterium-tritium neutrons.

The Review of scientific instruments·2024
Same author

Non-adiabatic direct quantum dynamics using force fields: Toward solvation.

The Journal of chemical physics·2024
Same author

Report of a Case of Diphtheria with Rare Complications.

The Southern medical record·2022
Same author

Asymmetric expression of proteins in the granules of the placentomal Binucleate cells in Giraffa camelopardalis†.

Biology of reproduction·2022
Same author

Interspecific and intraspecific foraging differentiation of neighbouring tropical seabirds.

Movement ecology·2021
Same author

Effect of estradiol preceding and progesterone subsequent to ovulation on proportion of postpartum beef cows pregnant.

Animal reproduction science·2021

Area of Science:

  • Oncology
  • Neuroscience
  • Pharmacology

Background:

  • Ifosfamide and mesna are used in chemotherapy.
  • Encephalopathy is a potential adverse effect of ifosfamide/mesna treatment.

Purpose of the Study:

  • To prospectively assess ifosfamide/mesna-induced encephalopathy.
  • To identify risk factors and clinical characteristics of this complication.

Main Methods:

  • Prospective assessment of 18 consecutive cases of encephalopathy post-ifosfamide/mesna chemotherapy.
  • Clinical evaluation, including neurological status and plasma potassium levels.
  • Analysis of relationship with tumor type, chemotherapy response, and survival.

Main Results:

  • Encephalopathy onset ranged from 12 to 146 hours post-infusion, with a median duration of 3 days.

Related Experiment Videos

  • Hypokalemia (plasma potassium < 3.0 mmol/l) was observed in 10 patients at encephalopathy onset.
  • Incomplete recovery occurred in two patients, and median survival post-encephalopathy was 25 days.
  • The incidence was 11% in 82 patients, with low sensitivity (18%) for a predictive nomogram.

    • Conclusions:

    • Ifosfamide/mesna encephalopathy is a severe and potentially irreversible complication.
    • Predicting this adverse event remains challenging.
    • Hypokalemia is a significant finding associated with ifosfamide/mesna-induced encephalopathy.